Drug Type AAV based gene therapy |
Synonyms Limb Girdle Muscular Dystrophy 2i(CRD), CRD 003, CRD003 |
Target |
Action stimulants |
Mechanism FKRP stimulants(Fukutin-related protein stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (United States) |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Muscular Dystrophy, Limb-Girdle, Type 2I | Preclinical | United States | 11 Apr 2024 |





